title: Deletion and translocation involving chromosome 3 (p14) in two tumorigenic Kaposi's sarcoma cell lines.
abstract: BACKGROUND
  Two neoplastic Kaposi's sarcoma (KS) cell lines, KS Y-1 (derived from a patient with KS associated with acquired immunodeficiency syndrome) and KS SLK (derived from an immunosuppressed patient with a renal transplant and KS or iatrogenic KS), have been shown to have abnormal chromosome constitution and to require no exogenous growth factors. They produce malignant tumors in immunodeficient mice. In contrast, all other cell cultures prepared in the past from KS specimens have shown to have normal diploid characteristics are hyperplastic, and depends on cytokines for growth, but they do not produce malignant tumors in immunodeficient mice.
  
  
  OBJECTIVE
  We investigated whether the chromosomal changes that occurred in these KS cell lines were random contribute to the pathogenesis of KS.
  
  
  METHODS
  We used the conventional G-banding technique and fluorescence in sti hybridization to identify structural and numerical chromosomal changes in the KS cell lines.
  
  
  RESULTS
  We demonstrated that both cell lines are aneuploid and have some additional features in common, i.e., loss of copies of chromosomes 14 and 21 and nonrandom translocations and deletions in the short arm of chromosome 3 at region 3p14. These KS cell lines also exhibits loss of heterozygosity of loci at region 3p14-ter.
  
  
  CONCLUSIONS
  This is the first time nonrandom chromosomal alterations have been described in KS neoplastic cells. On the basis of information available on other available on other cancers, the chromosome 3 alterations observed here can be expected to contribute to the neoplastic process in KS.
  
  
  CONCLUSIONS
  Future research should focus on the identification cytogenetic markers, thus facilitating generation of specific molecular probes for detecting neoplastic cells early in the disease process.
authors.affiliation: National Institute of health, Bethesda, MD 20892-4255, USA.
authors.forename: N C
authors.initials: NC
authors.lastname: Popescu
authors.forename: D B
authors.initials: DB
authors.lastname: Zimonjic
authors.forename: S
authors.initials: S
authors.lastname: Leventon-Kriss
authors.forename: J L
authors.initials: JL
authors.lastname: Bryant
authors.forename: Y
authors.initials: Y
authors.lastname: Lunardi-Iskandar
authors.forename: R C
authors.initials: RC
authors.lastname: Gallo
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000818:Animals; D002460:Cell Line; D002871:Chromosome Banding; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D002878:Chromosomes, Human, Pair 1; D002893:Chromosomes, Human, Pair 3; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D007680:Kidney Neoplasms / Q000276:immunology; D051379:Mice; D012514:Sarcoma, Kaposi / Q000209:etiology / Q000235:genetics*; D014178:Translocation, Genetic; D014407:Tumor Cells, Cultured